APO Research

APO RESEARCH · REPORT

Veterinary API Manufacturing

Selected research

Market Analysis & Forecast

Global Veterinary API Manufacturing Market Analysis and Forecast 2026-2032

Market perspective

The global Veterinary API Manufacturing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Veterinary API Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Veterinary API Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Veterinary API Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Veterinary API Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Veterinary API Manufacturing include Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Jiangsu Lingyun Pharmaceutical Co., Ltd., SUANFARMA, Ofichem Group, NGL Fine-Chem Ltd., Menadiona, FIS - Fabbrica Italiana Sintetici S.p.A, Excel Industries Ltd. and Alivira Animal Health Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Veterinary API Manufacturing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Veterinary API Manufacturing, also provides the revenue of main regions and countries. Of the upcoming market potential for Veterinary API Manufacturing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary API Manufacturing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary API Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Veterinary API Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Veterinary API Manufacturing Segment by Company

Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.

Jiangsu Lingyun Pharmaceutical Co., Ltd.

SUANFARMA

Ofichem Group

NGL Fine-Chem Ltd.

Menadiona

FIS - Fabbrica Italiana Sintetici S.p.A

Excel Industries Ltd.

Alivira Animal Health Ltd.

Afton Pharma

Veterinary API Manufacturing Segment by Type

NSAIDs

Anti-infectives

Antiparasitic

Biologics

Vaccines

Others

Veterinary API Manufacturing Segment by Application

In House

Contract Outsourcing

Veterinary API Manufacturing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary API Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary API Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary API Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Veterinary API Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Veterinary API Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary API Manufacturing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary API Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. NSAIDs Major Player Table 3. Anti-infectives Major Player Table 4. Antiparasitic Major Player Table 5. Biologics Major Player Table 6. Vaccines Major Player Table 7. Others Major Player Table 8. Global Veterinary API Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. In House Major Player Table 10. Contract Outsourcing Major Player Table 11. Veterinary API Manufacturing Industry Trends Table 12. Veterinary API Manufacturing Industry Drivers Table 13. Veterinary API Manufacturing Industry Opportunities and Challenges Table 14. Veterinary API Manufacturing Industry Restraints Table 15. Global Veterinary API Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Veterinary API Manufacturing Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Veterinary API Manufacturing Market Share by Region (2021-2026) Table 18. Global Veterinary API Manufacturing Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Veterinary API Manufacturing Market Share by Region (2027-2032) Table 20. Global Veterinary API Manufacturing Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Veterinary API Manufacturing Revenue Market Share by Players (2021-2026) Table 22. Global Veterinary API Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Veterinary API Manufacturing Key Players Headquarters & Area Served Table 24. Global Veterinary API Manufacturing Players, Product Type & Application Table 25. Global Veterinary API Manufacturing Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Veterinary API Manufacturing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Veterinary API Manufacturing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Veterinary API Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Veterinary API Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Veterinary API Manufacturing Revenue Market Share by Type (2021-2026) Table 32. Global Veterinary API Manufacturing Revenue Market Share by Type (2027-2032) Table 33. Global Veterinary API Manufacturing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Veterinary API Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Veterinary API Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Veterinary API Manufacturing Revenue Market Share by Application (2021-2026) Table 37. Global Veterinary API Manufacturing Revenue Market Share by Application (2027-2032) Table 38. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Company Information Table 39. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Business Overview Table 40. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Product Portfolio Table 42. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Recent Development Table 43. Jiangsu Lingyun Pharmaceutical Co., Ltd. Company Information Table 44. Jiangsu Lingyun Pharmaceutical Co., Ltd. Business Overview Table 45. Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Product Portfolio Table 47. Jiangsu Lingyun Pharmaceutical Co., Ltd. Recent Development Table 48. SUANFARMA Company Information Table 49. SUANFARMA Business Overview Table 50. SUANFARMA Veterinary API Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. SUANFARMA Veterinary API Manufacturing Product Portfolio Table 52. SUANFARMA Recent Development Table 53. Ofichem Group Company Information Table 54. Ofichem Group Business Overview Table 55. Ofichem Group Veterinary API Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Ofichem Group Veterinary API Manufacturing Product Portfolio Table 57. Ofichem Group Recent Development Table 58. NGL Fine-Chem Ltd. Company Information Table 59. NGL Fine-Chem Ltd. Business Overview Table 60. NGL Fine-Chem Ltd. Veterinary API Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. NGL Fine-Chem Ltd. Veterinary API Manufacturing Product Portfolio Table 62. NGL Fine-Chem Ltd. Recent Development Table 63. Menadiona Company Information Table 64. Menadiona Business Overview Table 65. Menadiona Veterinary API Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Menadiona Veterinary API Manufacturing Product Portfolio Table 67. Menadiona Recent Development Table 68. FIS - Fabbrica Italiana Sintetici S.p.A Company Information Table 69. FIS - Fabbrica Italiana Sintetici S.p.A Business Overview Table 70. FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Product Portfolio Table 72. FIS - Fabbrica Italiana Sintetici S.p.A Recent Development Table 73. Excel Industries Ltd. Company Information Table 74. Excel Industries Ltd. Business Overview Table 75. Excel Industries Ltd. Veterinary API Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Excel Industries Ltd. Veterinary API Manufacturing Product Portfolio Table 77. Excel Industries Ltd. Recent Development Table 78. Alivira Animal Health Ltd. Company Information Table 79. Alivira Animal Health Ltd. Business Overview Table 80. Alivira Animal Health Ltd. Veterinary API Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Alivira Animal Health Ltd. Veterinary API Manufacturing Product Portfolio Table 82. Alivira Animal Health Ltd. Recent Development Table 83. Afton Pharma Company Information Table 84. Afton Pharma Business Overview Table 85. Afton Pharma Veterinary API Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Afton Pharma Veterinary API Manufacturing Product Portfolio Table 87. Afton Pharma Recent Development Table 88. North America Veterinary API Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Veterinary API Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Veterinary API Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 91. North America Veterinary API Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 92. North America Veterinary API Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. North America Veterinary API Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 94. North America Veterinary API Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 95. Europe Veterinary API Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Veterinary API Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Veterinary API Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Veterinary API Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Veterinary API Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Europe Veterinary API Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Veterinary API Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 102. China Veterinary API Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 103. China Veterinary API Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 104. China Veterinary API Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 105. China Veterinary API Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia Veterinary API Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 107. Asia Veterinary API Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 108. Asia Veterinary API Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 109. Asia Veterinary API Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia Veterinary API Manufacturing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Asia Veterinary API Manufacturing Revenue by Region (US$ Million) & (2021-2026) Table 112. Asia Veterinary API Manufacturing Revenue by Region (US$ Million) & (2027-2032) Table 113. SAMEA Veterinary API Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 114. SAMEA Veterinary API Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 115. SAMEA Veterinary API Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 116. SAMEA Veterinary API Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 117. SAMEA Veterinary API Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. SAMEA Veterinary API Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 119. SAMEA Veterinary API Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Veterinary API Manufacturing Image Figure 2. Global Veterinary API Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary API Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 4. NSAIDs Image Figure 5. Anti-infectives Image Figure 6. Antiparasitic Image Figure 7. Biologics Image Figure 8. Vaccines Image Figure 9. Others Image Figure 10. Global Veterinary API Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Veterinary API Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 12. In House Image Figure 13. Contract Outsourcing Image Figure 14. Global Veterinary API Manufacturing Market Size (US$ Million) & (2021-2032) Figure 15. Global Veterinary API Manufacturing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Veterinary API Manufacturing Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Veterinary API Manufacturing Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Veterinary API Manufacturing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Veterinary API Manufacturing Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Veterinary API Manufacturing Revenue Market Share by Type (2021-2032) Figure 22. Global Veterinary API Manufacturing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Veterinary API Manufacturing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Veterinary API Manufacturing Revenue Market Share by Application (2021-2032) Figure 25. North America Veterinary API Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Veterinary API Manufacturing Revenue Share by Type (2021-2032) Figure 27. North America Veterinary API Manufacturing Revenue Share by Application (2021-2032) Figure 28. North America Veterinary API Manufacturing Revenue Share by Country (2021-2032) Figure 29. United States Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Veterinary API Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Veterinary API Manufacturing Revenue Share by Type (2021-2032) Figure 34. Europe Veterinary API Manufacturing Revenue Share by Application (2021-2032) Figure 35. Europe Veterinary API Manufacturing Revenue Share by Country (2021-2032) Figure 36. Germany Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Veterinary API Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Veterinary API Manufacturing Revenue Share by Type (2021-2032) Figure 46. China Veterinary API Manufacturing Revenue Share by Application (2021-2032) Figure 47. Asia Veterinary API Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Veterinary API Manufacturing Revenue Share by Type (2021-2032) Figure 49. Asia Veterinary API Manufacturing Revenue Share by Application (2021-2032) Figure 50. Asia Veterinary API Manufacturing Revenue Share by Region (2021-2032) Figure 51. Japan Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Veterinary API Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Veterinary API Manufacturing Revenue Share by Type (2021-2032) Figure 59. SAMEA Veterinary API Manufacturing Revenue Share by Application (2021-2032) Figure 60. SAMEA Veterinary API Manufacturing Revenue Share by Country (2021-2032) Figure 61. Brazil Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Veterinary API Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • NSAIDs
  • Anti-infectives
  • Antiparasitic
  • Biologics
  • Vaccines
  • Others
Applications
  • In House
  • Contract Outsourcing
Companies covered
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • Jiangsu Lingyun Pharmaceutical Co., Ltd.
  • SUANFARMA
  • Ofichem Group
  • NGL Fine-Chem Ltd.
  • Menadiona
  • FIS - Fabbrica Italiana Sintetici S.p.A
  • Excel Industries Ltd.
  • Alivira Animal Health Ltd.
  • Afton Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary API Manufacturing Market by Type
  3. 1.2.1 Global Veterinary API Manufacturing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 NSAIDs
  5. 1.2.3 Anti-infectives
  6. 1.2.4 Antiparasitic
  7. 1.2.5 Biologics
  8. 1.2.6 Vaccines
  9. 1.2.7 Others
  10. 1.3 Veterinary API Manufacturing Market by Application
  11. 1.3.1 Global Veterinary API Manufacturing Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 In House
  13. 1.3.3 Contract Outsourcing
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Veterinary API Manufacturing Market Dynamics
  1. 2.1 Veterinary API Manufacturing Industry Trends
  2. 2.2 Veterinary API Manufacturing Industry Drivers
  3. 2.3 Veterinary API Manufacturing Industry Opportunities and Challenges
  4. 2.4 Veterinary API Manufacturing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Veterinary API Manufacturing Market Perspective (2021-2032)
  2. 3.2 Global Veterinary API Manufacturing Growth Trends by Region
  3. 3.2.1 Global Veterinary API Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary API Manufacturing Market Size by Region (2021-2026)
  5. 3.2.3 Global Veterinary API Manufacturing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Veterinary API Manufacturing Revenue by Players
  2. 4.1.1 Global Veterinary API Manufacturing Revenue by Players (2021-2026)
  3. 4.1.2 Global Veterinary API Manufacturing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Veterinary API Manufacturing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary API Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Veterinary API Manufacturing Key Players Headquarters & Area Served
  7. 4.4 Global Veterinary API Manufacturing Players, Product Type & Application
  8. 4.5 Global Veterinary API Manufacturing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Veterinary API Manufacturing Market CR5 and HHI
  11. 4.6.3 2025 Veterinary API Manufacturing Tier 1, Tier 2, and Tier 3
5 Veterinary API Manufacturing Market Size by Type
  1. 5.1 Global Veterinary API Manufacturing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Veterinary API Manufacturing Revenue by Type (2021-2032)
  3. 5.3 Global Veterinary API Manufacturing Revenue Market Share by Type (2021-2032)
6 Veterinary API Manufacturing Market Size by Application
  1. 6.1 Global Veterinary API Manufacturing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Veterinary API Manufacturing Revenue by Application (2021-2032)
  3. 6.3 Global Veterinary API Manufacturing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  2. 7.1.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Company Information
  3. 7.1.2 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Business Overview
  4. 7.1.3 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Veterinary API Manufacturing Product Portfolio
  6. 7.1.5 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. Recent Developments
  7. 7.2 Jiangsu Lingyun Pharmaceutical Co., Ltd.
  8. 7.2.1 Jiangsu Lingyun Pharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Jiangsu Lingyun Pharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Jiangsu Lingyun Pharmaceutical Co., Ltd. Veterinary API Manufacturing Product Portfolio
  12. 7.2.5 Jiangsu Lingyun Pharmaceutical Co., Ltd. Recent Developments
  13. 7.3 SUANFARMA
  14. 7.3.1 SUANFARMA Company Information
  15. 7.3.2 SUANFARMA Business Overview
  16. 7.3.3 SUANFARMA Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 SUANFARMA Veterinary API Manufacturing Product Portfolio
  18. 7.3.5 SUANFARMA Recent Developments
  19. 7.4 Ofichem Group
  20. 7.4.1 Ofichem Group Company Information
  21. 7.4.2 Ofichem Group Business Overview
  22. 7.4.3 Ofichem Group Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ofichem Group Veterinary API Manufacturing Product Portfolio
  24. 7.4.5 Ofichem Group Recent Developments
  25. 7.5 NGL Fine-Chem Ltd.
  26. 7.5.1 NGL Fine-Chem Ltd. Company Information
  27. 7.5.2 NGL Fine-Chem Ltd. Business Overview
  28. 7.5.3 NGL Fine-Chem Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 NGL Fine-Chem Ltd. Veterinary API Manufacturing Product Portfolio
  30. 7.5.5 NGL Fine-Chem Ltd. Recent Developments
  31. 7.6 Menadiona
  32. 7.6.1 Menadiona Company Information
  33. 7.6.2 Menadiona Business Overview
  34. 7.6.3 Menadiona Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Menadiona Veterinary API Manufacturing Product Portfolio
  36. 7.6.5 Menadiona Recent Developments
  37. 7.7 FIS - Fabbrica Italiana Sintetici S.p.A
  38. 7.7.1 FIS - Fabbrica Italiana Sintetici S.p.A Company Information
  39. 7.7.2 FIS - Fabbrica Italiana Sintetici S.p.A Business Overview
  40. 7.7.3 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 FIS - Fabbrica Italiana Sintetici S.p.A Veterinary API Manufacturing Product Portfolio
  42. 7.7.5 FIS - Fabbrica Italiana Sintetici S.p.A Recent Developments
  43. 7.8 Excel Industries Ltd.
  44. 7.8.1 Excel Industries Ltd. Company Information
  45. 7.8.2 Excel Industries Ltd. Business Overview
  46. 7.8.3 Excel Industries Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Excel Industries Ltd. Veterinary API Manufacturing Product Portfolio
  48. 7.8.5 Excel Industries Ltd. Recent Developments
  49. 7.9 Alivira Animal Health Ltd.
  50. 7.9.1 Alivira Animal Health Ltd. Company Information
  51. 7.9.2 Alivira Animal Health Ltd. Business Overview
  52. 7.9.3 Alivira Animal Health Ltd. Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Alivira Animal Health Ltd. Veterinary API Manufacturing Product Portfolio
  54. 7.9.5 Alivira Animal Health Ltd. Recent Developments
  55. 7.10 Afton Pharma
  56. 7.10.1 Afton Pharma Company Information
  57. 7.10.2 Afton Pharma Business Overview
  58. 7.10.3 Afton Pharma Veterinary API Manufacturing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Afton Pharma Veterinary API Manufacturing Product Portfolio
  60. 7.10.5 Afton Pharma Recent Developments
8 North America
  1. 8.1 North America Veterinary API Manufacturing Revenue (2021-2032)
  2. 8.2 North America Veterinary API Manufacturing Revenue by Type (2021-2032)
  3. 8.2.1 North America Veterinary API Manufacturing Revenue by Type (2021-2026)
  4. 8.2.2 North America Veterinary API Manufacturing Revenue by Type (2027-2032)
  5. 8.3 North America Veterinary API Manufacturing Revenue Share by Type (2021-2032)
  6. 8.4 North America Veterinary API Manufacturing Revenue by Application (2021-2032)
  7. 8.4.1 North America Veterinary API Manufacturing Revenue by Application (2021-2026)
  8. 8.4.2 North America Veterinary API Manufacturing Revenue by Application (2027-2032)
  9. 8.5 North America Veterinary API Manufacturing Revenue Share by Application (2021-2032)
  10. 8.6 North America Veterinary API Manufacturing Revenue by Country
  11. 8.6.1 North America Veterinary API Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Veterinary API Manufacturing Revenue by Country (2021-2026)
  13. 8.6.3 North America Veterinary API Manufacturing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Veterinary API Manufacturing Revenue (2021-2032)
  2. 9.2 Europe Veterinary API Manufacturing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Veterinary API Manufacturing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Veterinary API Manufacturing Revenue by Type (2027-2032)
  5. 9.3 Europe Veterinary API Manufacturing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Veterinary API Manufacturing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Veterinary API Manufacturing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Veterinary API Manufacturing Revenue by Application (2027-2032)
  9. 9.5 Europe Veterinary API Manufacturing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Veterinary API Manufacturing Revenue by Country
  11. 9.6.1 Europe Veterinary API Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Veterinary API Manufacturing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Veterinary API Manufacturing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Veterinary API Manufacturing Revenue (2021-2032)
  2. 10.2 China Veterinary API Manufacturing Revenue by Type (2021-2032)
  3. 10.2.1 China Veterinary API Manufacturing Revenue by Type (2021-2026)
  4. 10.2.2 China Veterinary API Manufacturing Revenue by Type (2027-2032)
  5. 10.3 China Veterinary API Manufacturing Revenue Share by Type (2021-2032)
  6. 10.4 China Veterinary API Manufacturing Revenue by Application (2021-2032)
  7. 10.4.1 China Veterinary API Manufacturing Revenue by Application (2021-2026)
  8. 10.4.2 China Veterinary API Manufacturing Revenue by Application (2027-2032)
  9. 10.5 China Veterinary API Manufacturing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary API Manufacturing Revenue (2021-2032)
  2. 11.2 Asia Veterinary API Manufacturing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Veterinary API Manufacturing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Veterinary API Manufacturing Revenue by Type (2027-2032)
  5. 11.3 Asia Veterinary API Manufacturing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Veterinary API Manufacturing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Veterinary API Manufacturing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Veterinary API Manufacturing Revenue by Application (2027-2032)
  9. 11.5 Asia Veterinary API Manufacturing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Veterinary API Manufacturing Revenue by Country
  11. 11.6.1 Asia Veterinary API Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Veterinary API Manufacturing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Veterinary API Manufacturing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary API Manufacturing Revenue (2021-2032)
  2. 12.2 SAMEA Veterinary API Manufacturing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Veterinary API Manufacturing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Veterinary API Manufacturing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Veterinary API Manufacturing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Veterinary API Manufacturing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Veterinary API Manufacturing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Veterinary API Manufacturing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Veterinary API Manufacturing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Veterinary API Manufacturing Revenue by Country
  11. 12.6.1 SAMEA Veterinary API Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Veterinary API Manufacturing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Veterinary API Manufacturing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research